Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/165898 |
Resumo: | The gut microbiota is a group of over 38 trillion bacterial cells in the human microbiota that plays an important role in the regulation of human metabolism through its symbiotic relationship with the host. Changes in the gut microbial ecosystem are associated with increased susceptibility to metabolic disease in humans. However, the composition of the gut microbiota in those with type 2 diabetes mellitus and in the pathogenesis of metabolic diseases is not well understood. This article reviews the relationship between environmental factors and the gut microbiota in individuals with type 2 diabetes mellitus. Finally, we discuss the goal of treating type 2 diabetes mellitus by modifying the gut microbiota and the challenges that remain in this area. |
id |
USP-19_8dcb37e5b166e344a57d5973c70884bf |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/165898 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challengesType 2 Diabetes MellitusGut MicrobiotaEnvironmental FactorsThe gut microbiota is a group of over 38 trillion bacterial cells in the human microbiota that plays an important role in the regulation of human metabolism through its symbiotic relationship with the host. Changes in the gut microbial ecosystem are associated with increased susceptibility to metabolic disease in humans. However, the composition of the gut microbiota in those with type 2 diabetes mellitus and in the pathogenesis of metabolic diseases is not well understood. This article reviews the relationship between environmental factors and the gut microbiota in individuals with type 2 diabetes mellitus. Finally, we discuss the goal of treating type 2 diabetes mellitus by modifying the gut microbiota and the challenges that remain in this area.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2020-01-22info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://www.revistas.usp.br/clinics/article/view/16589810.6061/clinics/2020/e1277Clinics; Vol. 75 (2020); e1277Clinics; v. 75 (2020); e1277Clinics; Vol. 75 (2020); e12771980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/165898/158763https://www.revistas.usp.br/clinics/article/view/165898/159728Copyright (c) 2020 Clinicsinfo:eu-repo/semantics/openAccessLiu, YanfenLou, Xueyong2020-01-22T14:29:33Zoai:revistas.usp.br:article/165898Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2020-01-22T14:29:33Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges |
title |
Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges |
spellingShingle |
Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges Liu, Yanfen Type 2 Diabetes Mellitus Gut Microbiota Environmental Factors |
title_short |
Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges |
title_full |
Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges |
title_fullStr |
Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges |
title_full_unstemmed |
Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges |
title_sort |
Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges |
author |
Liu, Yanfen |
author_facet |
Liu, Yanfen Lou, Xueyong |
author_role |
author |
author2 |
Lou, Xueyong |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Liu, Yanfen Lou, Xueyong |
dc.subject.por.fl_str_mv |
Type 2 Diabetes Mellitus Gut Microbiota Environmental Factors |
topic |
Type 2 Diabetes Mellitus Gut Microbiota Environmental Factors |
description |
The gut microbiota is a group of over 38 trillion bacterial cells in the human microbiota that plays an important role in the regulation of human metabolism through its symbiotic relationship with the host. Changes in the gut microbial ecosystem are associated with increased susceptibility to metabolic disease in humans. However, the composition of the gut microbiota in those with type 2 diabetes mellitus and in the pathogenesis of metabolic diseases is not well understood. This article reviews the relationship between environmental factors and the gut microbiota in individuals with type 2 diabetes mellitus. Finally, we discuss the goal of treating type 2 diabetes mellitus by modifying the gut microbiota and the challenges that remain in this area. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-01-22 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/165898 10.6061/clinics/2020/e1277 |
url |
https://www.revistas.usp.br/clinics/article/view/165898 |
identifier_str_mv |
10.6061/clinics/2020/e1277 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/165898/158763 https://www.revistas.usp.br/clinics/article/view/165898/159728 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/xml |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 75 (2020); e1277 Clinics; v. 75 (2020); e1277 Clinics; Vol. 75 (2020); e1277 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222764684017664 |